✦ LIBER ✦

Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study

✍ Scribed by Maltazou, H; Whimbey, E; Abi-Said, D; Przepiorka, D; Champlain, R; Goodrich, J M

Book ID: 110012186
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 50 KB
Volume: 24
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701948

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytomegalovirus prophylaxis with gancicl

Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies

✍ T. Said; M.R.N. Nampoory; K.V. Johny; A.S. Pacsa; P. Mini Abraham; M.P. Nair; M. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Effective oral ganciclovir prophylaxis a

Effective oral ganciclovir prophylaxis against cytomegalovirus disease in heart transplant recipients

✍ G.M Mullen; M.A Silver; K Malinowska; C.E Lawless; R.C Lichtenberg; P.C Barath; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Comparison of cytomegalovirus antigenemi

Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis

✍ Nicholson, V A; Whimbey, E; Champlin, R; Abi-Said, D; Przepiorka, D; Tarrand, J; 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB

Cytomegalovirus Disease in High-Risk Tra

Cytomegalovirus Disease in High-Risk Transplant Recipients Despite Ganciclovir or Valganciclovir Prophylaxis

✍ Enver Akalin; Vinita Sehgal; Scott Ames; Sabera Hossain; Lisa Daly; Murphy Barba 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Increased incidence of cytomegalovirus i

Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis

✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos

Ganciclovir prophylaxis for cytomegalovi

Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone

✍ A Lo; R.J Stratta; M.F Egidi; A.T Kizilisik; M.H Shokouh-Amiri; H.P Grewal; J Tr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 70 KB